tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CARM Stock Latest News

Carisma Therapeutics reports data from its CAR-M therapy
The FlyCarisma Therapeutics reports data from its CAR-M therapy
12d ago
CARM
MRNA
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
PremiumThe Fly
Carisma Therapeutics reports Q3 EPS (31c), consensus (26c)
13d ago
CARM
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
PremiumThe Fly
Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
15d ago
CARM
MRNA
Carisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Carisma Therapeutics, Inc. (CARM) Q3 Earnings Cheat Sheet
15d ago
CARM
Leadership Transition at Carisma Therapeutics’ Board of Directors
PremiumCompany Announcements
Leadership Transition at Carisma Therapeutics’ Board of Directors
21d ago
8K
CARM
Alphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
PremiumThe FlyAlphabet upgraded, Boeing downgraded: Wall Street’s top analyst calls
21d ago
BA
CWH
Carisma Therapeutics initiated with a Buy at EF Hutton
Premium
The Fly
Carisma Therapeutics initiated with a Buy at EF Hutton
21d ago
CARM
Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
Premium
The Fly
Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
2M ago
CARM
MRNA
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
PremiumThe Fly
Carisma Therapeutics reports Q2 EPS (27c), consensus (30c)
3M ago
CARM
Carisma Therapeutics Board Changes and New Compensation Plans
PremiumCompany Announcements
Carisma Therapeutics Board Changes and New Compensation Plans
5M ago
8K
CARM
Carisma Therapeutics announces changes to its board of directors
PremiumThe Fly
Carisma Therapeutics announces changes to its board of directors
5M ago
CARM
Carisma Therapeutics nominates first candidate under collaboration with Moderna
PremiumThe Fly
Carisma Therapeutics nominates first candidate under collaboration with Moderna
5M ago
CARM
MRNA
Carisma Therapeutics granted FDA Fast Track designation for CT-0525
PremiumThe FlyCarisma Therapeutics granted FDA Fast Track designation for CT-0525
5M ago
CARM
Carisma Therapeutics management to meet virtually with BTIG
Premium
The Fly
Carisma Therapeutics management to meet virtually with BTIG
5M ago
CARM
Carisma Therapeutics Grants Executive Stock Options for Retention
Premium
Company Announcements
Carisma Therapeutics Grants Executive Stock Options for Retention
5M ago
8K
CARM
Carisma Therapeutics: First patient dosed in Phase 1 clinical trial of CT-0525
PremiumThe Fly
Carisma Therapeutics: First patient dosed in Phase 1 clinical trial of CT-0525
6M ago
CARM
Carisma Therapeutics price target lowered to $8 from $9 at H.C. Wainwright
PremiumThe Fly
Carisma Therapeutics price target lowered to $8 from $9 at H.C. Wainwright
6M ago
CARM
Securing Success: The Crucial Role of IP Rights in Carisma Therapeutics’ Market Dominance
PremiumCompany Announcements
Securing Success: The Crucial Role of IP Rights in Carisma Therapeutics’ Market Dominance
6M ago
CARM
Carisma Therapeutics expects cash to fund operations into Q3 of 2025
PremiumThe Fly
Carisma Therapeutics expects cash to fund operations into Q3 of 2025
7M ago
CARM
Carisma Therapeutics reports Q1 EPS (46c), consensus (43c)
PremiumThe FlyCarisma Therapeutics reports Q1 EPS (46c), consensus (43c)
7M ago
CARM
Carisma Therapeutics presents data for macrophages in liver fibrosis
Premium
The Fly
Carisma Therapeutics presents data for macrophages in liver fibrosis
7M ago
CARM
Carisma Therapeutics appoints Eugene Kennedy as Chief Medical Officer
Premium
The Fly
Carisma Therapeutics appoints Eugene Kennedy as Chief Medical Officer
7M ago
CARM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >